Novaka Pharma SRL
0.8 FTENovaka Pharma reported total assets of €1.10m at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Aug 2026), with 0.8 full-time equivalent.
By total assets for 2025, Novaka Pharma ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Novaka Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +60 % Total assets -6 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novaka Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Aug 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 03 Aug 2023
- Year ended 31 Dec 2021filed on 09 Aug 2022
Novaka Pharma's financial analysis
- Solvency7.2%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novaka Pharma
Novaka Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0723.816.176
- VAT number
- BE0723816176
- Peppol
- Registered · 0208:0723816176 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Mar 2019
- Registered office
- 1400 Nivelles
- Size
- Micro · 0.8 FTE
- Latest accounts
- 2025 · filed on 03 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Novaka Pharma (SRL) has been based in Nivelles since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 31,857 € and equity of 78,789 €; its revenue is not published. With 0.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 7.2%, below the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Novaka Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apoteek Mommaert Retail sale of pharmaceutical products Beersel · balance sheet €1.09m
- Capavita Retail sale of pharmaceutical products Schoten · balance sheet €1.09m
- Van Geem Retail sale of pharmaceutical products Antwerp · balance sheet €1.08m
- Farma Noord Retail sale of pharmaceutical products Kalmthout · balance sheet €1.12m
- Chaspierre Holding Retail sale of pharmaceutical products Verviers · balance sheet €1.13m
- Pharmadvance Retail sale of pharmaceutical products Chièvres · balance sheet €1.07m
- Deltaphar Retail sale of pharmaceutical products Auderghem · balance sheet €1.14m
Frequently asked questions about Novaka Pharma
What is the revenue of Novaka Pharma?
Novaka Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Novaka Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0723816176 for Novaka Pharma, if the company is VAT-registered. Its company number (CBE) is 0723.816.176.
Where is the registered office of Novaka Pharma?
According to the CBE register, the registered office of Novaka Pharma is in 1400 Nivelles.
What is the equity of Novaka Pharma?
At the close of the 2025 financial year, the equity of Novaka Pharma amounts to 78,789 €, a solvency of 7.2% of total assets.
How many people work at Novaka Pharma?
0.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Novaka Pharma?
The register lists 1 active mandates at Novaka Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Novaka Pharma within its sector?
By total assets for 2025, Novaka Pharma ranks in the top half of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Novaka Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →